文献速递其他结缔组织病

机器学习分类器可将系统性硬化症个体患者分入内在分子亚群

A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets.
PubMed 文献 · Arthritis Rheumatol · 2019-09-02

研究基于3个独立基因表达队列合并的297份皮肤活检样本(102例患者及对照)训练机器学习算法,并在3个独立SSc队列(含不同微阵列平台的独立实验室数据)中外部验证,共分析413份皮肤活检样本(213人)。重复交叉验证平均分类准确率87.1%,外部验证平均准确率85.4%。该分类器可用于临床试验中为个体样本识别内在亚群。

要点

  • 多分类弹性网络分类器对SSc内在分子亚群平均分类准确率87.1%。
  • 外部验证平均准确率85.4%,含不同微阵列平台的独立实验室数据。
  • 该方法可为单个样本分配炎症、纤维增殖、正常样等内在亚群。

核心结论

  • 开发出高准确度的SSc分子亚群分类器,可对个体患者样本进行内在亚群分类。
  • 该方法可用于SSc临床试验中识别个体样本的内在亚群,并辅助临床决策与异质性分子信息解读。

研究设计与样本

  • 研究合并3个独立基因表达队列,构建覆盖102例独特患者及对照的297份皮肤活检样本数据集用于训练机器学习算法。
  • 采用3个独立SSc队列进行外部验证,包括独立实验室在不同微阵列平台上生成的数据集。
  • 训练与测试队列共分析413份皮肤活检样本,来自213名个体。

主要发现

  • 重复交叉折叠验证通过多分类弹性网络识别出一致且具判别力的标志物,平均分类准确率为87.1%,灵敏度和特异度均高。
  • 外部验证中分类器平均准确率为85.4%。
  • 重新分析既往研究数据,识别出代表经典炎症、纤维增殖和正常样亚群的患者分组。

关键数值与推荐

  • 重复交叉折叠验证平均分类准确率87.1%。
  • 外部验证平均准确率85.4%。

临床怎么用

  • 该分类器可用于SSc临床试验中为个体样本识别内在分子亚群。
  • 该方法提供数据驱动手段,辅助临床决策及解读SSc患者异质性分子信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-throughput gene expression profiling of tissue samples from patients with systemic sclerosis (SSc) has identified 4 "intrinsic" gene expression subsets: inflammatory, fibroproliferative, normal-like, and limited. Prior methods required agglomerative clustering of many samples. In order to classify individual patients in clinical trials or for diagnostic purposes, supervised methods that can assign single samples to molecular subsets are required. We undertook this study to introduce a novel machine learning classifier as a robust accurate intrinsic subset predictor. METHODS: Three independent gene expression cohorts were curated and merged to create a data set covering 297 skin biopsy samples from 102 unique patients and controls, which was used to train a machine learning algorithm. We performed external validation using 3 independent SSc cohorts, including a gene expression data set generated by an independent laboratory on a different microarray platform. In total, 413 skin biopsy samples from 213 individuals were analyzed in the training and testing cohorts. RESULTS: Repeated cross-fold validation identified consistent and discriminative markers using multinomial elastic net, performing with an average classification accuracy of 87.1% with high sensitivity and specificity. In external validation, the classifier achieved an average accuracy of 85.4%. Reanalyzing data from a previous study, we identified subsets of patients that represent the canonical inflammatory, fibroproliferative, and normal-like subsets. CONCLUSION: We developed a highly accurate classifier for SSc molecular subsets for individual patient samples. The method can be used in SSc clinical trials to identify an intrinsic subset on individual samples. Our method provides a robust data-driven approach to aid clinical decision-making and interpretation of heterogeneous molecular information in SSc patients.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Franks JM, Martyanov V, Cai G, et al. A Machine Learning Classifier for Assigning Individual Patients With Systemic Sclerosis to Intrinsic Molecular Subsets. Arthritis Rheumatol. 2019. PMID: 30920766. doi:10.1002/art.40898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。